In the title compound, C(30)H(22)BrNO(2), the cyclo-pentane ring of the dihydro-acenaphthyl-ene group and the pyrrolidine ring are both in envelope conformations with the spiro C atom and N atom, respectively, as the flap atom. The cyclo-pentane ring of the indane group adopts a half-chair conformation. A weak intra-molecular C-H⋯O hydrogen bond forms an S(8) ring motif. The naphthalene ring system of the dihydro-acenaphthyl-ene group forms dihedral angles of 41.76 (6) and 42.17 (6)° with the benzene ring of the bromo-phenyl group and the benzene ring of the indane group, respectively. The dihedral angle between the two benzene rings is 83.92 (7)°. In the crystal, mol-ecules are linked by weak C-H⋯O and C-H⋯N hydrogen bonds into a two-dimensional network parallel to the ac plane. Weak C-H⋯π inter-actions are also observed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344476PMC
http://dx.doi.org/10.1107/S1600536812014213DOI Listing

Publication Analysis

Top Keywords

cyclo-pentane ring
8
dihydro-acenaphthyl-ene group
8
ring indane
8
indane group
8
benzene ring
8
ring
7
group
5
4'-4-bromo-phen-yl-1'-methyl-dispiro-[acenaphthyl-ene-12'-pyrrolidine-3'2''-indane]-21''1h-dione title
4
title compound
4
compound c30h22brno2
4

Similar Publications

In the title compound, CHNO, the central five-membered cyclo-pentene ring adopts an envelope conformation while the five-membered spiro 2,3-di-hydro-1-pyrrole rings exhibit twisted envelope and envelope conformations. One of the 1,3-di-hydro-2-indol-2-one units is in an axial position and the other is in a bis-ectional position. The methyl methanimidate unit is in an equatorial position.

View Article and Find Full Text PDF

The mol-ecule of the title compound, CHClNO, is generated by a crystallographic inversion centre at the midpoint of the central C-C bond. A kink in the mol-ecule is defined by a torsion angle of -169.86 (15)° about this central bond of the alkyl bridge.

View Article and Find Full Text PDF

The mol-ecule of the title compound, CHBrNO, comprises a fused tricyclic system consisting of two five-membered rings (cyclo-pentane and tetra-hydro-furan) and one six-membered ring (tetra-hydro-pyridinone). Both five-membered rings of the tricyclic system have envelope conformations, and the conformation of the six-membered cycle is inter-mediate between chair and half-chair. In the crystal, the mol-ecules are linked by C-H⋯O hydrogen bonds and C-H⋯π, C-Br⋯π and C⋯O inter-actions into double layers.

View Article and Find Full Text PDF

The chiral title compound, CHNO, which can be used for producing active pharmaceutical ingredients for treatment of type 2 pancreatic diabetes and other pathologies dependent on insulin resistance, was prepared from (1,3)-camphoric acid and -phenyl-enedi-amine. It crystallized from an ethanol solution in the chiral monoclinic space group. The five-membered ring adopts a twisted conformation with the methyl-substituted C atoms displaced by -0.

View Article and Find Full Text PDF

The title compound, CHNO, (), is conformationally unstable; the predominant form present in its solution is the β-pyran-ose form (74.3%), followed by the β- and α-furan-oses (12.1 and 10.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!